Press release
Cataract Market Poised for Growth by 2032: estimates DelveInsight | Companies - Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer, Teva Pharma, Amorphex Therapeutics, Alcon, Astellas Pharma, Bayer, Novartis, AstraZeneca, Amgen, Carl Zeiss Medi
(Albany, USA) DelveInsight's "Cataract Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cataract, historical and forecasted epidemiology as well as the Cataract market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.The Cataract market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cataract market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cataract treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cataract market.
Request for a Free Sample Report @ https://www.delveinsight.com/report-store/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Cataract Market Report are:
• According to DelveInsight, Cataract market size is expected to grow at a decent CAGR by 2032.
• Leading Cataract companies working in the market are Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer Inc, Teva Pharmaceutical, Amorphex Therapeutics, Alcon, Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca, Amgen, Carl Zeiss Meditec, HumanOptics Holding AG, STAAR SURGICAL, SIFI SpA, Sintesi Research Srl, EyePoint Pharmaceuticals, Alcon Research, Nacuity Pharmaceuticals, TearLab Corporation and others.
• Rising Incidence of Cataract and increasing Demand for Retail Pharmacies are some of the factors affecting cataract market growth.
• Key Cataract Therapies expected to launch in the market are NETILDEX™ eye drops solution, Dexamethasone, Prednisolone Acetate Ophthalmic, MELT-300, Midazolam, Ketamine, Healon, Amvisc Plus, NPI-002 Intravitreal Implant, Dexycu, Vigadexa, and others.
Cataract Overview
Cataract is a common eye condition that affects the lens of the eye, causing it to become cloudy. The lens is responsible for focusing light onto the retina at the back of the eye, allowing us to see clear images. When a cataract develops, it interferes with the normal passage of light, leading to blurred or hazy vision.
Cataracts typically develop slowly over time and are more commonly seen in older individuals. However, they can also occur in younger people due to various factors such as genetics, trauma to the eye, certain medications, or medical conditions like diabetes. Long-term exposure to ultraviolet radiation from the sun, smoking, and alcohol consumption may also increase the risk of developing cataracts.
Learn more about Cataract treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cataract Market
The Cataract market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Cataract market trends by analyzing the impact of current Cataract therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Cataract market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Cataract market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Cataract market in 7MM is expected to witness a major change in the study period 2019-2032.
Cataract Epidemiology
The Cataract epidemiology section provides insights into the historical and current Cataract patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Cataract market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Cataract Epidemiology @ https://www.delveinsight.com/report-store/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cataract Drugs Uptake
This section focuses on the uptake rate of the potential Cataract drugs recently launched in the Cataract market or expected to be launched in 2019-2032. The analysis covers the Cataract market uptake by drugs, patient uptake by therapies, and sales of each drug.
Cataract Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Cataract market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Cataract Pipeline Development Activities
The Cataract report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Cataract key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Cataract pipeline development activities @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cataract Therapeutics Assessmen
Major key companies are working proactively in the Cataract Therapeutics market to develop novel therapies which will drive the Cataract treatment markets in the upcoming years are Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer Inc, Teva Pharmaceutical, Amorphex Therapeutics, Alcon, Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca, Amgen, Carl Zeiss Meditec, HumanOptics Holding AG, STAAR SURGICAL, SIFI SpA, Sintesi Research Srl, EyePoint Pharmaceuticals, Alcon Research, Nacuity Pharmaceuticals, TearLab Corporation and others.
Learn more about the emerging Cataract therapies & key companies @ https://www.delveinsight.com/sample-request/cataract-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cataract Report Key Insights
1. Cataract Patient Population
2. Cataract Market Size and Trends
3. Key Cross Competition in the Cataract Market
4. Cataract Market Dynamics (Key Drivers and Barriers)
5. Cataract Market Opportunities
6. Cataract Therapeutic Approaches
7. Cataract Pipeline Analysis
8. Cataract Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Cataract Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Cataract Competitive Intelligence Analysis
4. Cataract Market Overview at a Glance
5. Cataract Disease Background and Overview
6. Cataract Patient Journey
7. Cataract Epidemiology and Patient Population
8. Cataract Treatment Algorithm, Current Treatment, and Medical Practices
9. Cataract Unmet Needs
10. Key Endpoints of Cataract Treatment
11. Cataract Marketed Products
12. Cataract Emerging Therapies
13. Cataract Seven Major Market Analysis
14. Attribute Analysis
15. Cataract Market Outlook (7 major markets)
16. Cataract Access and Reimbursement Overview
17. KOL Views on the Cataract Market
18. Cataract Market Drivers
19. Cataract Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Trending Reports:
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Polycythemia Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Ambulatory Arrhythmia Monitoring Devices Market: https://www.delveinsight.com/report-store/ambulatory-arrhythmia-monitoring-devices-market
• Choroidal Neovascularization Market: https://www.delveinsight.com/report-store/choroidal-neovascularization-market
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Cardiopulmonary Bypass Equipment Market: https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market
• Chemotherapy Induced Anemia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-anemia-market
• Chronic Bronchitis Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Clbp Market: https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Pemphigus Vulgaris Market: https://www.delveinsight.com/infographics/pemphigus-vulgaris-market
• Polycythemia Vera Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Advanced Renal Cell Carcinoma Market: https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Allergic Conjunctivitis Market: https://www.delveinsight.com/report-store/allergic-conjunctivitis-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alport Syndrome Market: https://www.delveinsight.com/report-store/alport-syndrome-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Bladder Pain Syndrome Market: https://www.delveinsight.com/report-store/interstitial-cystitis-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market
• Brain Aneurysm Stents Market: https://www.delveinsight.com/report-store/brain-aneurysm-stents-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Chronic Inflammatory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Chronic Inflammtory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myeloid-leukemia-market
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/report-store/cutaneous-t-cell-lymphoma-ctcl-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Eczema Market: https://www.delveinsight.com/report-store/atopic-dermatitis-market
Contact Info:
Ankit Nigam
Assistant Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cataract Market Poised for Growth by 2032: estimates DelveInsight | Companies - Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer, Teva Pharma, Amorphex Therapeutics, Alcon, Astellas Pharma, Bayer, Novartis, AstraZeneca, Amgen, Carl Zeiss Medi here
News-ID: 3346145 • Views: …
More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…

Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…

Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…

Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Cataract
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying alternatives to conventional cataract extraction surgery. Advances in molecular biology, oxidative stress modulation, and crystallin protein stabilization have opened new avenues for pharmacological intervention. Companies like Nacuity Pharmaceuticals, CGeneTech, and Plex Pharmaceuticals are pioneering efforts to develop novel agents aimed at delaying, halting, or reversing…
Cataract Surgery Devices Market - Innovation Meets Precision: Elevate Cataract S …
Newark, New Castle, USA: The "Cataract Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cataract Surgery Devices Market: https://www.growthplusreports.com/report/cataract-surgery-devices-market/7846
This latest report researches the industry structure,…
Intraocular Lens Implants for Cataract Market is Driven by the Increasing Incide …
The proposed Intraocular Lens Implants for Cataract Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The Intraocular Lens Implants for Cataract Market…
Potential Opportunities of Cataract Surgical Devices Market
The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user…
Cataract Devices Market Forecast by 2015: QY Research, Inc.
According to a new report published by QY Research, Titled “Global Cataract Devices Market Professional Survey Report 2018,” by Company Profile Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development has been featured on QY Research.
Cataract Surgery is the removal of the eye’s clouded natural lens, and replacing it with an artificial lens that helps restore vision to the eye. Without removing the cataract surgically, most patients with…
Cataract Surgery Devices Market Opportunity Analysis, 2018-2026
Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes.
Although cataract does not interfere with the eyesight in the early stages, it…